Botulinum toxin injection in the pediatric population with medically refractory neuropathic bladder.

Journal: Journal of pediatric urology
PMID: 26778185

Abstract

INTRODUCTION: Botulinum toxin injection (BTI) has been advocated as a second line therapy in management of neuropathic bladder in pediatric population for refractory patients to conventional medical management such as anticholinergics. The purpose was to review the safety and efficacy of BTI in children with neuropathic bladder refractory to conservative non-surgical measures. We hypothesized that BTI would be an effective alternative to bladder augmentation in certain patients but not all.

Authors

  • M K Khan
    Division of Urology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Electronic address: drkamrankhan@icloud.com.
  • B A VanderBrink
    Division of Urology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Electronic address: brian.vanderbrink@cchmc.org.
  • W R DeFoor
    Division of Urology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Electronic address: Bob.DeFoor@cchmc.org.
  • E Minevich
    Division of Urology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Electronic address: Eugene.Minevich@cchmc.org.
  • E Jackson
    Division of Urology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Electronic address: Elizabeth.Jackson@cchmc.org.
  • P Noh
    Division of Urology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Electronic address: Paul.Noh@cchmc.org.
  • P P Reddy
    Division of Urology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Electronic address: Pramod.Reddy@cchmc.org.

Keywords

External Resources

Popular Topics
Recent Journals